Medicare confirms payment for prostate cancer drug
(AP) -- Medicare officials confirmed Thursday that the program will cover the $93,000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease ...
Jun 30, 2011
0
0